Transcriptome analysis of distinct mouse strains reveals kinesin light chain-1 splicing as an amyloid-β accumulation modifier (original) (raw)
Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model
Marielza Nunes
2020
View PDFchevron_right
Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer's disease susceptibility
Ishaan Gupta
Nature genetics, 2018
View PDFchevron_right
Alternative Splicing in Alzheimer's Disease
Troy Rohn
Journal of Parkinson's disease and Alzheimer's disease, 2015
View PDFchevron_right
Transcriptomics in Alzheimer’s Disease: Aspects and Challenges
Seong An
International Journal of Molecular Sciences
View PDFchevron_right
Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease
Nenad Bogdanovic
International Journal of Molecular Medicine, 2007
View PDFchevron_right
The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease
Christine Hulette
Journal of Neurochemistry, 2006
View PDFchevron_right
Brain Transcriptome Sequencing of a Natural Model of Alzheimer's Disease
Rodrigo Vasquez
Frontiers in aging neuroscience, 2017
View PDFchevron_right
Genetic Deletion or Antagonism of Kinin B1 and B2RECEPTORS Improves Cognitive Deficits in a Mouse Model of Alzheimer's Disease
G. Passos
2008
View PDFchevron_right
Identification of a novel alternative splicing isoform of human amyloid precursor protein gene, APP639
rivka ravid
European Journal of Neuroscience, 2003
View PDFchevron_right
Alzheimer's Disease beta A4 Protein Release and Amyloid Precursor Protein Sorting Are Regulated by Alternative Splicing
Colin Masters
Journal of Biological Chemistry, 1996
View PDFchevron_right
Signaling Mechanisms that Mediate Aβ Induced Neuronal Dysfunction
Jorge Busciglio
Alzheimer’s Disease, 2007
View PDFchevron_right
Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer's Disease
Seth Love
Journal of Alzheimer's disease : JAD, 2017
View PDFchevron_right
Neuronal ELAVL proteins utilize AUF-1 as a co-partner to induce neuron-specific alternative splicing of APP
Apostolia Fragkouli
Scientific reports, 2017
View PDFchevron_right
Splicing therapeutics for Alzheimer's disease
Catherine Wasser
EMBO molecular medicine, 2016
View PDFchevron_right
A novel APP/Aβ mutation K16N produces highly toxic heteromeric Aβ oligomers
Ulrich Finckh, Peter Hildebrand, Lisa Munter
Alzheimer's & Dementia, 2011
View PDFchevron_right
Kinin B2 receptor can play a neuroprotective role in Alzheimer's disease
T. Viel
Neuropeptides, 2015
View PDFchevron_right
Transcriptional, Behavioral and Biochemical Profiling in the 3xTg-AD Mouse Model Reveals a Specific Signature of Amyloid Deposition and Functional Decline in Alzheimer’s Disease
Federico Bermudez-Rattoni
Frontiers in Neuroscience, 2020
View PDFchevron_right
Amyloid accumulation drives proteome-wide alterations in mouse models of Alzheimer’s disease like pathology
Jeffrey Savas
2017
View PDFchevron_right
Aβ Inhibition of Kinesin 5 Disrupts the Localization and Function of Membrane Proteins: Implications for Neuronal Responses to Neurotrophins, Neurotransmitters, Glucose, and Lipids in Ad
Csilla Ari
Alzheimer's & Dementia, 2014
View PDFchevron_right
Alternative splicing in a presenilin 2 variant associated with Alzheimer disease
Ellen Wijsman
Annals of clinical and translational neurology, 2019
View PDFchevron_right
New insights on the genetic etiology of Alzheimer’s and related dementia
Florentino Sanchez Garcia
2020
View PDFchevron_right
Amyloid-beta-dependent phosphorylation of collapsin response mediator protein-2 dissociates kinesin in Alzheimer's disease
Bayden Wood
Neural regeneration research, 2018
View PDFchevron_right
APP Processing and the APP-KPI Domain Involvement in the Amyloid Cascade
Manuel Menéndez-gonzález
Neurodegenerative Diseases, 2005
View PDFchevron_right
Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways
Daniel Geschwind
Proceedings of the …, 2010
View PDFchevron_right
Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
David Vanderwall
Molecular Neurodegeneration, 2021
View PDFchevron_right
New Insights into the Molecular Bases of Familial Alzheimer’s Disease
Valeria D'Argenio
Journal of Personalized Medicine, 2020
View PDFchevron_right
Investigating Splicing Variants Uncovered by Next-Generation Sequencing the Alzheimer’s Disease Candidate Genes, CLU, PICALM, CR1, ABCA7, BIN1, the MS4A Locus, CD2AP, EPHA1 and CD33
James C Turton
Journal of Alzheimer’s Disease & Parkinsonism, 2016
View PDFchevron_right